Biofire lab test kits and products BPA call order
Ended Awarded
- Contract number
- 19AQMM26F7014
- Awardee
-
Biofire Defense LLC UEI NHMDGM122546
- Awarding agency
-
Office of Acquisition Management
Department of State
- Obligated
- $6,929
Award facts
- Opportunity
-
- Notice of Intent to Sole-Source to BioFire Defense LLC for laboratory testing supplies and kits Special Notice · 19AQMM25Q0012 · Posted Dec 5, 2024
- Contract value 100% obligated
- $6,928.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Bureau of Administration Department of State
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Millcreek, UT 84107, USA
Award details come from SAM.gov/FPDS.
About this award
Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, has been awarded a $6,928.72 firm fixed-price call order under a Blanket Purchase Agreement with the Department of State's Bureau of Administration for BioFire lab test kits and products. This Total Small Business set-aside award, issued on December 22, 2025, with completion targeted for January 30, 2026, represents a call against the larger $4.5 million BPA that covers specialized laboratory testing supplies. The BPA encompasses products including FilmArray Respiratory Panel 2.1 tests, Gastrointestinal Panel tests, and Global Fever Special Pathogens tests—diagnostic solutions designed to support the State Department's biodefense and public health preparedness capabilities.
Biofire Defense has positioned itself as a critical federal vendor through its advanced diagnostic platforms, including the FilmArray and RAZOR Mk II systems, which identify biological agents and support infectious disease detection. The company maintains a robust portfolio of federal contracts across multiple agencies, including the Department of Defense, National Institutes of Health, and Defense Health Agency. This call order demonstrates continued reliance on Biofire Defense's diagnostic capabilities, with the company's Other Transaction agreement worth approximately $21 million with the Joint Program Executive Office for Chemical and Biological Defense further underscoring its strategic importance to federal biodefense initiatives.
Quick answers
Who was awarded contract 19AQMM26F7014?
19AQMM26F7014 was awarded to Biofire Defense LLC by Office of Acquisition Management (Department of State) on December 22, 2025.
How much is contract 19AQMM26F7014 worth?
The government has obligated $6,929 on 19AQMM26F7014.
Which agency awarded contract 19AQMM26F7014?
Office of Acquisition Management (Department of State) awarded 19AQMM26F7014, with funding from Bureau of Administration (Department of State).
Is contract 19AQMM26F7014 an order under another contract?
Yes. 19AQMM26F7014 is a BPA call under 19AQMM25A0465, a blanket purchase agreement.
Was contract 19AQMM26F7014 competed?
The extent of competition for 19AQMM26F7014 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award